Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this retrospective observational study was to analyze the effect of targeted
therapies administered as second-line treatment after failure of pazopanib as well as
increase the amount of information available on efficacy and safety of pazopanib as a
first-line therapy in practice usual for the clinical treatment of metastatic Renal
Carcinoma.